Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
4.130
-0.670 (-13.96%)
Feb 21, 2025, 4:00 PM EST - Market closed
Neuronetics Employees
Neuronetics had 203 employees as of December 31, 2023. The number of employees increased by 9 or 4.64% compared to the previous year.
Employees
203
Change (1Y)
9
Growth (1Y)
4.64%
Revenue / Employee
$358,182
Profits / Employee
-$179,424
Market Cap
229.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
STIM News
- 14 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - GlobeNewsWire
- 24 days ago - NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression - GlobeNewsWire
- 2 months ago - Neuronetics and Greenbrook TMS Announce Closing of Transaction - GlobeNewsWire
- 3 months ago - Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - GlobeNewsWire